PA Medical News about Macular Edema

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema
Ophthalmology, 10/05/09

Gillies MC et al. – The majority of eyes that initially improved with IVTA maintained their gain after 5 years. No new safety concerns were identified. IVTA treatment may be considered in carefully selected cases of impaired vision caused by advanced DME that are unresponsive to other interventions.

Bevacizumab Improves Macular Edema
Review of Ophthalmology, 10/02/09 Relevance Score: 69%

Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion
European Journal of Ophthalmology, 11/13/09 Relevance Score: 68%

Is multifocal ERG a reliable index of macular function after triamcinolone acetonide injection in diffuse diabetic macular edema
European Journal of Ophthalmology, 11/11/09 Relevance Score: 68%

Pegaptanib Sodium for Macular Edema Secondary to Branch Retinal Vein Occlusion
American Journal of Ophthalmology, 10/30/09 Relevance Score: 68%

Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions
Retina, 11/17/09 Relevance Score: 66%